These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

878 related items for PubMed ID: 3005399

  • 21. Lymphokine-activated killer (LAK) cell phenomenon. IV. Lysis by LAK cell clones of fresh human tumor cells from autologous and multiple allogeneic tumors.
    Rayner AA, Grimm EA, Lotze MT, Wilson DJ, Rosenberg SA.
    J Natl Cancer Inst; 1985 Jul; 75(1):67-75. PubMed ID: 2989604
    [Abstract] [Full Text] [Related]

  • 22. Clonal analysis of the involvement of T11 molecules in antigen receptor-mediated T lymphocyte functions.
    Moretta A, Pantaleo G, Lopez-Botet M, Carrel S, Moretta L.
    Behring Inst Mitt; 1985 Aug; (77):39-47. PubMed ID: 2417584
    [Abstract] [Full Text] [Related]

  • 23. p40, a novel surface molecule involved in the regulation of the non-major histocompatibility complex-restricted cytolytic activity in humans.
    Poggi A, Pella N, Morelli L, Spada F, Revello V, Sivori S, Augugliaro R, Moretta L, Moretta A.
    Eur J Immunol; 1995 Feb; 25(2):369-76. PubMed ID: 7875198
    [Abstract] [Full Text] [Related]

  • 24. Human T cell clones exerting multiple cytolytic activities show heterogeneity in susceptibility to inhibition by monoclonal antibodies.
    van de Griend RJ, Giphart MJ, Van Krimpen BA, Bolhuis RL.
    J Immunol; 1984 Sep; 133(3):1222-9. PubMed ID: 6205072
    [Abstract] [Full Text] [Related]

  • 25. Involvement of T11 molecules in antigen receptor-mediated T lymphocyte functions: effect of anti-T11 monoclonal antibody on functional capabilities of alloreactive T cell clones.
    Moretta A, Pantaleo G, Lopez-Botet M, Mingari MC, Carrel S, Moretta L.
    Eur J Immunol; 1985 Aug; 15(8):841-4. PubMed ID: 3161746
    [Abstract] [Full Text] [Related]

  • 26. Analysis of the role of interferon-gamma, interleukin 2 and a third factor distinct from interferon-gamma and interleukin 2 in human B cell proliferation. Evidence that they act at different times after B cell activation.
    Romagnani S, Giudizi GM, Almerigogna F, Biagiotti R, Alessi A, Mingari C, Liang CM, Moretta L, Ricci M.
    Eur J Immunol; 1986 Jun; 16(6):623-9. PubMed ID: 3087756
    [Abstract] [Full Text] [Related]

  • 27. Anti-CD3 + IL-2-stimulated murine killer cells. In vitro generation and in vivo antitumor activity.
    Anderson PM, Blazar BR, Bach FH, Ochoa AC.
    J Immunol; 1989 Feb 15; 142(4):1383-94. PubMed ID: 2521662
    [Abstract] [Full Text] [Related]

  • 28. A novel type of human T cell clone with highly potent natural killer-like cytotoxicity divorced from large granular lymphocyte morphology.
    Schneider EM, Pawelec GP, Liangru S, Wernet P.
    J Immunol; 1984 Jul 15; 133(1):173-9. PubMed ID: 6609974
    [Abstract] [Full Text] [Related]

  • 29. Heterogeneity of long-term cultured activated killer cells induced by anti-T3 antibody.
    Yun YS, Hargrove ME, Ting CC.
    J Immunol; 1988 Aug 15; 141(4):1390-7. PubMed ID: 3260924
    [Abstract] [Full Text] [Related]

  • 30. Fucose-activated killer (FAK) cells: anomalous killers with augmented cytotoxic activity.
    Stanková J, Rola-Pleszczynski M.
    J Immunol; 1985 Dec 15; 135(6):3719-28. PubMed ID: 2415584
    [Abstract] [Full Text] [Related]

  • 31. Assignment of human natural killer (NK)-like cells to the T cell lineage. Single allospecific T cell clones lyse specific or NK-sensitive target cells via distinct recognition structures.
    Moretta A, Pantaleo G, Mingari MC, Melioli G, Moretta L, Cerottini JC.
    Eur J Immunol; 1984 Feb 15; 14(2):121-5. PubMed ID: 6230242
    [Abstract] [Full Text] [Related]

  • 32. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F, Hashimoto W, Okamura H, Robbins PD, Lotze MT, Tahara H.
    Cancer Res; 2000 Sep 01; 60(17):4838-44. PubMed ID: 10987295
    [Abstract] [Full Text] [Related]

  • 33. Induction of human lymphokine-activated killer cells by IFN-alpha and IFN-gamma.
    Ellis TM, McKenzie RS, Simms PE, Helfrich BA, Fisher RI.
    J Immunol; 1989 Dec 15; 143(12):4282-6. PubMed ID: 2512355
    [Abstract] [Full Text] [Related]

  • 34. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and gamma/delta TCR+ T lymphocytes. II. Modulation of natural killer cytotoxicity by anti-Kp43 monoclonal antibody.
    Aramburu J, Balboa MA, Izquierdo M, López-Botet M.
    J Immunol; 1991 Jul 15; 147(2):714-21. PubMed ID: 1830071
    [Abstract] [Full Text] [Related]

  • 35. Induction of cytolytic activity by anti-T3 monoclonal antibody. Activation of alloimmune memory cells and natural killer cells from normal and immunodeficient individuals.
    Suthanthiran M, Williams PS, Solomon SD, Rubin AL, Stenzel KH.
    J Clin Invest; 1984 Dec 15; 74(6):2263-71. PubMed ID: 6392343
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones.
    Parronchi P, De Carli M, Manetti R, Simonelli C, Sampognaro S, Piccinni MP, Macchia D, Maggi E, Del Prete G, Romagnani S.
    J Immunol; 1992 Nov 01; 149(9):2977-83. PubMed ID: 1401925
    [Abstract] [Full Text] [Related]

  • 38. Killer cell recruitment and renewal capacity of purified cytolytic and noncytolytic human peripheral blood natural killer cell subsets.
    Lebow LT, Jewett A, Bonavida B.
    J Immunol; 1993 Jan 01; 150(1):320-9. PubMed ID: 8417130
    [Abstract] [Full Text] [Related]

  • 39. Clonal and frequency analyses of tumor-infiltrating T lymphocytes from human solid tumors.
    Miescher S, Whiteside TL, Moretta L, von Fliedner V.
    J Immunol; 1987 Jun 01; 138(11):4004-11. PubMed ID: 3108380
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 44.